Form 4 for CL Colgate-Palmolive
Accepted 2026-09-18 16:10:26 ET · period of report 2026-09-16 · accession 0001225208-26-007888 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-18 16:10 | 2026-09-16 | CL | Wallace Noel R. | COB, Pres, CEO, Dir | A - Grant | $0.00 | +29.6K | 379.7K | +8% | $0 |
| D | 2026-09-18 16:10 | 2026-09-16 | CL | Wallace Noel R. | COB, Pres, CEO, Dir | A - Grant | $0.00 | +205.2K | 205.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-16 | A | A | 29,649 | $0.00 | 379,700 | D | — | — | (F1) Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-09-16 | A | A | 205,197 | $0.00 | 205,197 | D | $87.02 · — to 2036-09-16 | 205,197 Common Stock | (F2) Stock option award granted under the issuer's incentive compensation plan. (F3) Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 16, 2026 grant date. |